Michael A. Gorin

Michael Gorin practices at Mount Sinai Doctors-Greenlawn in Greenlawn, New York.

Michael Gorin's NPI, 1881991495, was assigned on February 16, 2011. Michael Gorin graduated from University of Miami, Miller School of Medicine in 2011. Michael Gorin holds New York license 313957.

Michael Gorin's primary practice is Mount Sinai Doctors-Greenlawn, at 5 Cuba Hill Road, Greenlawn, NY 11740. The practice phone is (631) 628-5000.

Michael Gorin's primary practice is Mount Sinai Doctors-Greenlawn in Greenlawn, New York. Michael Gorin is also affiliated with Mount Sinai South Nassau. The medical group on file is Mount Sinai Doctors Long Island. Dmand AI also links Michael Gorin to 2 more group practices and clinics and 1 medical group, each named with a free account. Michael Gorin's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Gorin practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Michael Gorin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Michael Gorin's licenses on file in 2 states: New York and Maryland.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Michael Gorin treats.

CMS data shows 8,912 Medicare services from Michael Gorin across 39 procedure codes in 2024, for 787 Medicare patients. Medicare paid $314,804 for them.

CMS counts 787 Medicare patients who saw Michael Gorin in 2024. The largest group is 65 to 74, with 322 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Gorin's median patient age at 69, with 18% women.

In 2024, Michael Gorin wrote 1,713 Medicare Part D claims for 418 patients. 95% of them were for generic drugs. CMS names the drug for 1,634 of them, across 19 drugs with 11 or more claims each, at $57,824 in total drug cost. In 2023, CMS named 751 claims across 13 drugs.

Michael Gorin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of prostate resection by Michael Gorin, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 292 papers to Michael Gorin, published from 2009 to 2025. 2017 was the busiest year, with 28. The most frequent topics are Prostatic Neoplasms, Kidney Neoplasms and Carcinoma, Renal Cell. Michael Gorin has published most often in Urology. Michael Gorin's most frequent co-authors are Mohamad E. Allaf, MD, Martin Gilbert Pomper, MD, PhD and Mark Wayne Ball, MD.

CMS Open Payments shows 148 general payments to Michael Gorin from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. KOELIS Inc. paid the most, $53,245.

Dmand AI lists 1 award for Michael Gorin, most recently AOA Inductee 2011 in 2011.

Michael Gorin graduated from University of Miami, Miller School of Medicine in 2011. Michael Gorin is a member of AOA, AUA, Endourological Society and Focal Therapy Society.

Michael Gorin is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.